Medical Device Buyers
For the medical device buyers team that needs independent sources before an actual spending, legal or operating decision.
Review scope →Specialist divisions / Pharmaceuticals, Biotechnology & Medical Device Intelligence
Specialist evidence services
Pharmaceuticals, Biotechnology & Medical Device Intelligence
What is the authoritative product, trial and regulatory-record status?
Who commissions this work
Life Sciences Counsel
For the life sciences counsel team that needs independent sources before an actual spending, legal or operating decision.
Review scope →Health Investors
For the health investors team that needs independent sources before an actual spending, legal or operating decision.
Review scope →The real purchase trigger
FDA communication, study update, device recall or partner review
Reconcile product identifiers, sponsor identity, clinical registry and regulator notices.
We make the client’s claim, the original record, conflicting sources and the unknowns readable before commitment.
Choose one of eight defined services
Medical Device Regulatory Evidence Brief
One named subject or event; up to three material claims; agreed source jurisdictions and date window. Deliverable: Source coverage sheet, first three contradictions or gaps, clear next-record requests.
Review service and acceptance →Identity decision · Identity & Source Map
One main entity or asset and up to four related names, owners, locations, records or aliases. Deliverable: Entity or asset-resolution table, link-confidence explanation and original source chain.
Review service and acceptance →Claim decision · Material Claims Verification
Up to five numbered claims from a supplied proposal, transaction pack or public statement. Deliverable: Claim-by-claim citations, opposite sources, date-sensitive uncertainty and unproved statements.
Review service and acceptance →Timing decision · Independent Chronology Reconstruction
One bounded event sequence; disclosed evidence window; source provenance and known omissions. Deliverable: Chronology chart, disputed-event table, original-record references and unresolved sequence.
Review service and acceptance →Counterparty decision · Counterparty & Relationship Check
Named entity and up to five related organisations or responsible entities identified from lawful records. Deliverable: Evidence-supported relationship diagram, mismatches, ownership questions and exposure caveats.
Review service and acceptance →Decision-pack review · Decision-Ready Evidence Dossier
One defined commercial decision, six critical questions, specified sources and no unlimited investigation. Deliverable: Executive decision memo, evidence/contradiction matrix, dated primary-source index and recommendations for further questions.
Review service and acceptance →Repeat-work pilot · Repeat-File Evidence Desk
Written pilot of up to ten defined file types, with sampling rules, turnaround assumptions and exclusions. Deliverable: Consistent file-by-file evidence cards, exception register and consolidated management view.
Review service and acceptance →Clinical & Device Public Record Watch
One named subject or a written small watchlist; specified public records, cadence, escalation threshold. Deliverable: Dated change log, evidence citations, false-positive dispositions and monthly change summary.
Review service and acceptance →Eight focused specialist pathways
Each pathway has a narrower research question, decision-ready evidence specification, source scope and written-commissioning path.
Pharmaceutical Regulatory Intelligence
Test the exact source and contrary evidence behind pharmaceutical regulatory intelligence, rather than commission a generic industry report.
Review scope →Medical Device Regulatory Research
Test the exact source and contrary evidence behind medical device regulatory research, rather than commission a generic industry report.
Review scope →Clinical Trial Intelligence
Test the exact source and contrary evidence behind clinical trial intelligence, rather than commission a generic industry report.
Review scope →Drug Development Pipeline Intelligence
Test the exact source and contrary evidence behind drug development pipeline intelligence, rather than commission a generic industry report.
Review scope →Biotechnology Company Intelligence
Test the exact source and contrary evidence behind biotechnology company intelligence, rather than commission a generic industry report.
Review scope →Medical Device Recall Monitoring
Test the exact source and contrary evidence behind medical device recall monitoring, rather than commission a generic industry report.
Review scope →Healthcare Product Claims Review
Test the exact source and contrary evidence behind healthcare product claims review, rather than commission a generic industry report.
Review scope →Life Sciences Partner & Licensing Intelligence
Test the exact source and contrary evidence behind life sciences partner & licensing intelligence, rather than commission a generic industry report.
Review scope →Research sources to test
The following sources may support this type of work; their existence is not a claim that a prospective client or named matter has been verified.
U.S. FDA device recall public API
Source to test against the actual claim, checked for effective dates, coverage and access limitations. Not a client-specific verification result.
Open source →US FDA clinical trials via ClinicalTrials.gov
Source to test against the actual claim, checked for effective dates, coverage and access limitations. Not a client-specific verification result.
Open source →openFDA status and data currency
Source to test against the actual claim, checked for effective dates, coverage and access limitations. Not a client-specific verification result.
Open source →Evidence deliverables and professional limits
What the decision owner receives
- Medical Device Regulatory Evidence Brief
- regulated product state brief
- trial-source crosswalk
- manufacturer evidence map
- Source-linked claim analysis
- Dated assumptions, contradictions and missing evidence
What remains outside the mandate
No medical advice, efficacy certification or approval determination.
Acceptance is conditional on conflict, jurisdiction, lawful access, data protection, capacity and written fee approval.
Start with the decision, not a large retainer
Buyer stages
Match the size of the assignment to the present decision.
Review scope →Example evidence pack
View the contents of an illustrative research output without invented findings.
Review scope →Fees & engagement
Understand written standard-fee proposals, pilot limits and the approval process.
Review scope →Evidence questions worth resolving
Decision questions
Contrary-evidence tests
Division evidence guide (PDF)
Change-monitoring method (PDF)Lawful-source coverage varies. The documents explain the proposed method; no case, professional certification, continuous watch or fee has been approved automatically.